Exosens SAS
PAR:EXENS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.234
49.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of EXENS.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
L3harris Technologies Inc
NYSE:LHX
|
|
| CH |
G
|
Garmin Ltd
NYSE:GRMN
|
|
| IN |
|
Bharat Electronics Ltd
NSE:BEL
|
|
| SE |
|
Hexagon AB
STO:HEXA B
|
|
| IL |
|
Elbit Systems Ltd
TASE:ESLT
|
|
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
|
| TR |
|
Aselsan Elektronik Sanayi ve Ticaret AS
IST:ASELS.E
|
|
| NO |
K
|
Kongsberg Gruppen ASA
OSE:KOG
|
|
| UK |
|
Halma PLC
LSE:HLMA
|
|
| CN |
C
|
China Spacesat Co Ltd
SSE:600118
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Exosens SAS
Balance Sheet Decomposition
Exosens SAS
| Current Assets | 313.8m |
| Cash & Short-Term Investments | 89.8m |
| Receivables | 118.1m |
| Other Current Assets | 105.9m |
| Non-Current Assets | 553.5m |
| Long-Term Investments | 3.9m |
| PP&E | 119.2m |
| Intangibles | 430.4m |
| Current Liabilities | 124.8m |
| Accounts Payable | 30.9m |
| Accrued Liabilities | 37.1m |
| Other Current Liabilities | 56.9m |
| Non-Current Liabilities | 313m |
| Long-Term Debt | 263.4m |
| Other Non-Current Liabilities | 49.7m |
Free Cash Flow Analysis
Exosens SAS
| Free Cash Flow |
Earnings Waterfall
Exosens SAS
|
Revenue
|
431.7m
|
|
Cost of Revenue
|
-109.1m
|
|
Gross Profit
|
322.6m
|
|
Operating Expenses
|
-231.9m
|
|
Operating Income
|
90.7m
|
|
Other Expenses
|
-35m
|
|
Net Income
|
55.7m
|
EXENS Profitability Score
Profitability Due Diligence
Exosens SAS's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Exosens SAS's profitability score is hidden . The higher the profitability score, the more profitable the company is.
EXENS Solvency Score
Solvency Due Diligence
Exosens SAS's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Exosens SAS's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EXENS Price Targets Summary
Exosens SAS
According to Wall Street analysts, the average 1-year price target for EXENS is 50.91 EUR with a low forecast of 37.37 EUR and a high forecast of 59.85 EUR.
Dividends
Current shareholder yield for EXENS is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?